Needham Downgrades Verrica Pharmaceuticals (VRCA) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. INTC
2. AMZN
3. COIN
4. RDDT
5. PINS
6. FSLR
7. DASH
8. SYK
9. SBUX
10. SNDK

Go back to Needham Downgrades Verrica Pharmaceuticals (VRCA) to Hold

Brookline Capital Markets Downgrades Verrica Pharmaceuticals (VRCA) to Hold

October 2, 2024 10:30 AM EDT

Brookline Capital Markets analyst Kemp Dolliver downgraded Verrica Pharmaceuticals (NASDAQ: VRCA) from Buy to Hold.


For an analyst ratings summary and ratings history on Verrica Pharmaceuticals click here. For more ratings news on Verrica Pharmaceuticals click here.


Shares of Verrica Pharmaceuticals closed at $1.37 yesterday.

... More

Verrica Pharmaceuticals (VRCA) Announces Restructuring of Commercial Organization

October 2, 2024 7:32 AM EDT

Verrica Pharmaceuticals Inc. (Verrica or the Company) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced a restructuring of its sales and operating teams to reduce costs and expand access to YCANTH® for the treatment of molluscum... More